Implementation of Standardized Early Identification and Diagnosis for Transthyretin Amyloidosis (ATTR) in High-Risk Populations

NCT07338942 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

4000

Enrollment

INDUSTRY

Sponsor class

Conditions

ATTR-CM

Interventions

BEHAVIORAL: implementation of standard early identification and diagnosis of ATTR

Sponsor

AstraZeneca